Delcath Systems (DCTH) Liabilities and Shareholders Equity (2010 - 2026)

Delcath Systems' (DCTH) quarterly Liabilities and Shareholders Equity came in at $124.8 million in Q1 2026, up 42.97% year-on-year from $87.3 million in Q1 2025, and up 0.98% quarter-over-quarter from $123.6 million in Q4 2025.

Delcath Systems (DCTH) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Delcath Systems' Liabilities and Shareholders Equity history runs 17 years deep, the most recent figure standing at $124.8 million for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 42.97% year-over-year to $124.8 million in Q1 2026; TTM through Mar 2026 was $489.6 million, a 113.35% increase from a year earlier, with the FY2025 full-year figure at $123.6 million, up 61.42% from the prior year.
  • Liabilities and Shareholders Equity grew to $124.8 million in Q1 2026 per DCTH's latest filing, from $123.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $124.8 million in Q1 2026 and bottomed at $17.9 million in Q4 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $36.1 million (2024), against an average of $57.6 million.
  • Across the five-year window, Liabilities and Shareholders Equity tumbled 46.08% in 2022 and jumped 292.33% in 2025, its largest moves.
  • Year by year, Liabilities and Shareholders Equity stood at $17.9 million in 2022, then surged by 116.17% to $38.6 million in 2023, then soared by 98.35% to $76.6 million in 2024, then surged by 61.42% to $123.6 million in 2025, then gained by 0.98% to $124.8 million in 2026.
  • Per Business Quant, the three latest DCTH Liabilities and Shareholders Equity figures stand at $124.8 million (Q1 2026), $123.6 million (Q4 2025), and $124.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 183.95 Bn 176.66 Bn 6.27 Bn 110.43 Bn
2 Stryker 128.83 Bn 125.95 Bn 3.81 Bn 46.29 Bn
3 Medtronic 108.81 Bn 99.59 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 68.39 Bn 66.94 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 48.28 Bn 44.60 Bn 1.29 Bn 13.32 Bn
6 Dexcom 28.39 Bn 27.27 Bn 750.30 Mn 6.63 Bn
7 GE HealthCare Technologies 28.30 Bn 26.01 Bn 1.98 Bn 37.13 Bn
8 Smith & Nephew 26.95 Bn 26.37 Bn - 10.46 Bn
9 Koninklijke Philips 25.45 Bn 22.32 Bn 2.07 Bn 31.92 Bn
10 Delcath Systems 429.73 Mn 340.43 Mn 21.26 Mn 124.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 124.84 Mn
Dec 31, 2025 123.63 Mn
Sep 30, 2025 124.30 Mn
Jun 30, 2025 116.88 Mn
Mar 31, 2025 87.32 Mn
Dec 31, 2024 76.59 Mn
Sep 30, 2024 31.68 Mn
Jun 30, 2024 33.91 Mn
Mar 31, 2024 36.10 Mn
Dec 31, 2023 38.61 Mn
Sep 30, 2023 47.58 Mn
Jun 30, 2023 21.05 Mn
Mar 31, 2023 30.60 Mn
Dec 31, 2022 17.86 Mn
Sep 30, 2022 20.23 Mn
Jun 30, 2022 21.07 Mn
Mar 31, 2022 27.32 Mn
Dec 31, 2021 33.12 Mn
Sep 30, 2021 34.43 Mn
Jun 30, 2021 24.92 Mn